Seeking AlphaTue, 05 May 2026 16:00:22 GMTViking Therapeutics: Market Betting On Big Upside Through 2030VKTX+1.21%
MarketBeatFri, 01 May 2026 14:45:56 GMTViking Therapeutics Faces Timeline Risk—But Upside Could Be HugeVKTX+1.21%
Zacks Investment ResearchThu, 30 Apr 2026 16:31:37 GMTVKTX Q1 Earnings Miss on Higher Phase 3 Development CostsVKTX+1.21%
Seeking AlphaThu, 30 Apr 2026 12:53:47 GMTViking Therapeutics Earnings: Q3 Maintenance Study Data A Potential WildcardVKTX+1.21%
Seeking AlphaThu, 30 Apr 2026 07:01:34 GMTViking Therapeutics, Inc. (VKTX) Q1 2026 Earnings Call TranscriptVKTX+1.21%
The Motley FoolSun, 26 Apr 2026 14:02:00 GMTThis Obesity Stock Could More Than Double Over the Next 12 Months, According to Wall StreetVKTX+1.21%
Zacks Investment ResearchThu, 23 Apr 2026 22:51:01 GMTViking Therapeutics, Inc. (VKTX) Suffers a Larger Drop Than the General Market: Key InsightsVKTX+1.21%
Zacks Investment ResearchTue, 21 Apr 2026 13:36:07 GMTViking Therapeutics Gears Up for Q1 Earnings: Here's What to ExpectVKTX+1.21%
The Motley FoolFri, 17 Apr 2026 09:10:00 GMTIs Viking Therapeutics the Ultimate Millionaire-Maker Obesity Stock for 2026?VKTX+1.21%
Zacks Investment ResearchTue, 14 Apr 2026 22:46:19 GMTViking Therapeutics, Inc. (VKTX) Exceeds Market Returns: Some Facts to ConsiderVKTX+1.21%
Zacks Investment ResearchTue, 14 Apr 2026 14:31:21 GMTIs Viking Therapeutics (VKTX) a Buy as Wall Street Analysts Look Optimistic?VKTX+1.21%
Zacks Investment ResearchMon, 13 Apr 2026 22:51:06 GMTViking Therapeutics, Inc. (VKTX) Surpasses Market Returns: Some Facts Worth KnowingVKTX+1.21%
Zacks Investment ResearchMon, 06 Apr 2026 22:46:21 GMTViking Therapeutics, Inc. (VKTX) Stock Dips While Market Gains: Key FactsVKTX+1.21%
The Motley FoolFri, 03 Apr 2026 19:26:00 GMTWhere Will Viking Therapeutics Stock Be in 10 Years?VKTX+1.21%
Zacks Investment ResearchMon, 30 Mar 2026 22:51:27 GMTViking Therapeutics, Inc. (VKTX) Declines More Than Market: Some Information for InvestorsVKTX+1.21%
The Motley FoolSun, 29 Mar 2026 04:30:00 GMT1 Reason This Biotech Stock Could Triple Before Year-EndVKTX+1.21%
Zacks Investment ResearchFri, 27 Mar 2026 15:01:08 GMTVKTX Finishes Enrollment in Second Late-Stage Study on Obesity DrugVKTX+1.21%
Zacks Investment ResearchTue, 24 Mar 2026 22:51:10 GMTWhy Viking Therapeutics, Inc. (VKTX) Dipped More Than Broader Market TodayVKTX+1.21%
The Motley FoolMon, 23 Mar 2026 19:00:00 GMTWhy Viking Therapeutics Stock Could Take Off Later This YearVKTX+1.21%
The Motley FoolWed, 11 Mar 2026 09:45:00 GMTHere's Why Viking Therapeutics Stock Recovered and Can Soar 2026VKTX+1.21%
